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Abstract Expectancies play a major role for the treat-
ment outcome of a broad variety of immune-mediated
conditions and may strengthen or mimic the effects of
regular long-term therapies. This study adds to a recent-
ly published study of Kox et al. (PNAS 111:7379–7384,
2014) on the ability to voluntarily influence the physi-
ological stress response in healthy men after a training
program consisting of meditation, breathing techniques,
and exposure to cold, which found highly promising
results on the clinical, autonomic, and immune response
to experimentally induced inflammation (using the ex-
perimental human endotoxemia model). Within this pro-
ject, a number of variables were included to assess the
role of generalized (optimism, neuroticism) and specific
outcome expectancies (related to the effects of the train-
ing on health) on the response to endotoxin administra-
tion after training. Indications were found that especially
the generalized outcome expectancy optimism is a po-
tential determinant of the autonomic (epinephrine: rho=
0.76, p< .01) and immune response (interleukin-10:
rho=0.60, p<.05) to induced inflammation after train-
ing, whereas more specific expectations with regard to
the effects of the training could be especially relevant
for the clinical symptom report (flu-like symptoms:
rho=−0.71, p<.01). This proof-of-principle study pro-
vides first indications for potential innovative treatments
to change immune-modulating responses by means of
psychological mechanisms. If replicated, these findings
may be used for predicting training responses and po-
tentiate their effects by means of optimism-inducing in-
terventions in patients with immune-mediated rheumatic
conditions.
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Introduction
Psychological factors are supposed to play a major role
for the treatment outcome of a broad variety of
immune-mediated conditions, such as rheumatoid arthri-
tis [1–3]. In particular, the broad literature on placebo
effects has been shown that expectancies about health
can induce immune responses that may directly and
positively influence health and treatment outcomes,
whereas negative expectancies about a treatment can
cause an inert substance to create harmful effects or
induce unwanted side effects [4–7]. For example, out-
come expectancies based on conditioning, such as par-
tial reinforcement of treatment dosages, could lead to a
significant reduction in active medication and reported
side effects in various conditions, without negatively
impacting disease activity and symptom reporting
[8–11]. In addition, outcome expectancies based on ver-
bal suggestions on the effectiveness of a treatment have
shown important in predicting treatment outcomes.
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However, particular promising effects have been found
for the combination of both (conditioning and verbal
suggestions) outcome expectancy mechanisms [8–13].
Thus, outcome expectancies may strengthen or mimic
the effects of regular long-term therapies and might be
used to find innovative ways to optimize the individual
treatment response in conditions requiring long-term
pharmacological treatment [6, 14, 15].
A case study of a Dutch individual Wim Hof, who has
developed a training program consisting ofmeditation, breath-
ing techniques, and exposure to cold to voluntarily influence
the physiological stress response, revealed that this individual
appeared to strongly activate the sympathetic nervous system
and attenuate the immune response in reaction to controlled
experimentally induced inflammation (using the experimental
human endotoxemia model) [16]. Recently, a proof-of-
principle randomized controlled trial (RCT) in 12 healthy
male volunteers compared to 12 non-trained volunteers exam-
ined the effects of this training program in others, showing
remarkably similar effects [17]. If replicated in a larger sam-
ple, such a training program could have important implica-
tions for the treatment of, for instance, autoimmune diseases.
In order to gain insight into potential variables that may
predict the effectiveness of such training, it is relevant to
know whether specific psychological variables, such as out-
come expectancies, are related to the response to the exper-
imental inflammation after training. More stable individual
differences (e.g. personality characteristics of optimism or
neuroticism) in expectancies can be distinguished from more
specific and situation-depending expectancies regarding the
outcome of a particular treatment or intervention (states of
specific outcome expectancies). The personality characteris-
tic of optimism (the general expectation that good things
will happen) and neuroticism (the tendency to experience
negative emotional states and to view the world as threaten-
ing) represents generalized (positive versus negative) out-
come expectancy characteristics, respectively. Both have
shown to predict future outcomes of morbidity and even
mortality in various populations and have been related to
stress system and immune system functioning [18–20]. Out-
come expectancies that are more specific, situation-depend-
ing, and directly focus on the outcomes of a certain treat-
ment have also shown to affect the stress and immune sys-
tems, next to effects on more clinical symptom reports
[6,20]. As outcome expectancies are assumed to change
the psychophysiological stress response, the role of outcome
expectancies may be especially visible and relevant in the
response to a stressor, such as induced inflammation [13].
The current study explores the role of generalized (opti-
mism, neuroticism) versus specific (directed to the training
effects) outcome expectancies in the clinical, autonomic, and
immune response elicited by endotoxin administration after
the previously described training program.
Materials and methods
Design
This study was performed as part of a proof-of-principle ran-
domized controlled trial in 24 healthy Dutch male volunteers.
The study protocol was approved by the local ethics commit-
tee of the Radboud University Medical Center (CMO2012/
454). All subjects provided written informed consent, and
the study was conducted in accordance with the Declaration
of Helsinki and Good Clinical Practice guidelines. As reported
in more detail in the paper previously published on the effects
of the training on the response to endotoxin administration
[17], subjects were screened and then randomly allocated to
the trained group (n=18, of whom 12were randomly assigned
to the endotoxemia experiment day) or the control group (n=
12). Participants filled out questionnaires on generalized out-
come expectancies before training and questions on specific
outcome expectancies before and after training and at the end
of the endotoxemia test day. The current study reports on the
results of the trained group.
Training program
The trained group was trained by four trainers. The 4-day
group program that took place in Poland consisted of three
main elements: 3rd eye meditation including visualizations
aimed at total relaxation, exposure to cold (e.g., dipping in
ice-cold water or hiking up a snowy mountain bare-chested),
and breathing techniques (hyperventilation followed by breath
retention and deep inhalations and exhalations). After the 4-
day group program, the subjects practiced the techniques they
learned daily by themselves at home (2–3 hours a day) until
the endotoxemia experiment day (5–9 days later). A final
group training took place, and at the end of this day, 12 trained
subjects were randomly selected for participation in the
endotoxemia experiments in order to allow for subject re-
placement in case of an adverse event or illness.
Experimental human endotoxemia model
The endotoxemia experiment took place at the intensive care
department of the Radboudumc. The procedures on the
endotoxemia experiment day are described elsewhere [17].
In short, purified lipopolysaccharide (LPS, US Standard Ref-
erence Endotoxin Escherichia coli O:113) solution was ad-
ministered as an i.v. bolus injection at a dose of 2 ng/kg body
weight in 1min at T0. From 30min before LPS administration
to 2.5 hours after administration, trained participants practiced
the breathing techniques (hyper/hypoventilation cycles for the
first 1.5 hours and deep inhalation and exhalation in combi-
nation with tightening muscles for the next hour).
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Measures
Outcome expectancies
Generalized outcome expectancies The Life Orientation
Test-Revised [21] was used to measure optimism by means
of six items (and four filler items) on a 5-point Likert scale
varying from Bstrongly disagree^ to Bstrongly agree.^ An ex-
ample item is BIn uncertain times, I usually expect the best.^
The neuroticism scale of the Big Five Inventory [22] was used
to measure neuroticism by means of eight items on a 5-point
Likert scale varying from Bdisagree strongly^ to Bagree
strongly.^ An example item is BI see myself as someone
who worries a lot.^
Specific outcome expectancies Four items were constructed
on expectancies regarding the effects of the training on the
response to endotoxin administration and on general health,
to be answered on a 10-point numeric rating scale varying
from Bno influence^ to Bvery much influence.^ The items
were BPlease indicate how much influence you think that the
training has on… 1) the functioning of your immune system,
2) your physical complaints (e.g., experiences of pain and
fatigue), 3) the degree to which you will experience physical
complaints after the administration of endotoxin, and 4) the
degree to which you will become sick from the administration
of endotoxin^. The internal consistency (Cronbach’s alpha) of
the items was .85.
Response to endotoxin administration In line with the main
study [17], the specific time point with the strongest clinical,
autonomic, or immune response to endotoxin administration
was used as outcome measurement.
Clinical symptom report LPS-induced flu-like symptoms
(headache, nausea, shivering, muscle, and back pain) at
90 min after endotoxin administration (T90) were scored on
a 6-point Likert scale varying from no symptoms to worst ever
experienced.
Autonomic response Details of the blood sampling and col-
lection is reported elsewhere [17]. Plasma epinephrine con-
centrations at the time of endotoxin administration (T0) were
measured using routine analysis methods also used for patient
samples (HPLCy with fluorometric detection).
Immune response Concentrations of the anti-inflammatory
cytokine interleukin (IL)-10 at 60 minutes after endotoxin ad-
ministration (T60), the pro-inflammatory cytokine tumor necro-
sis factor alpha (TNF-α) at 90minutes (T90), and IL-6 and IL-8
at 120 minutes after endotoxin administration (T120) were
measured using a simultaneous Luminex assay according to
the manufacturer’s instructions (Milliplex; Millipore) [17].
Statistical analysis
As we were interested specifically in the effects of outcome
expectancies on the response to endotoxin administration after
training and as specific outcome expectancies regarding the
effects of the training could only meaningfully be assessed in
the trained group (n=12), analyses were performed in the
trained group that underwent the endotoxin administration
only. Variables were screened for deviations of normality.
Changes in specific outcome expectancies from before the
training to after the experiment were explored by means of
analysis of variance. Spearman’s rank correlations between
outcome expectancies and the response to endotoxin admin-
istration were explored.
Results
Clinical, autonomic, and immune response elicited
by endotoxin administration
As reported in detail elsewhere [17], the trained group (n=12)
reported fewer flu-like symptoms; showed profoundly in-
creased plasma epinephrine levels at the start of the experi-
ment, followed by a more rapid and profound increase in anti-
Table 1 Spearman’s rank correlations of generalized and specific outcome expectancies with the clinical, autonomic, and immune response elicited by
endotoxin administration after the training program in healthy young men (n=12)
Response to endotoxin administration Clinical Autonomic Immune
Outcome expectancies Flu-like symptoms (T90) Epinephrine (T0) IL-10 (T60) TNF-α (T90) IL-6 (T120) IL-8 (T120)
Generalized outcome expectancies
Optimism (LOT-R) −.38 .76** .60* −.32 −.26 −.32
Neuroticism (BFI) .10 −.32 −.09 .27 .22 .11
Specific outcome expectancies −.71** .28 .33 .00 .16 −.15
IL interleukin, TNF tumor necrosis factor, LOT-R Life Orientation Test-Revised, BFI Big Five Inventory
*p<.05; **p<.01
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inflammatory IL-10 levels; and lower subsequent pro-
inflammatory TNF-α, IL-6, and IL-8 levels than the non-
trained group in response to endotoxin administration.
Outcome expectancies
As expected for healthy young males, participants in the
trained group were overall rather optimistic (M±SD=18.00
±3.46, range 12–24) and low in neuroticism (M±SD=2.11±
0.55, range 1.13–3.13), with both variables showing normal
distributions (skewness and kurtosis <.62). With regard to
specific outcome expectancies, participants showed an in-
crease in the expected effects of the training on their response
to endotoxin administration and health from before the train-
ing to after the endotoxemia experiment (before training:M±
SD=27.69±6.16, before endotoxemia experiment: M±SD=
31.68±3.11, after endotoxemia experiment: M±SD=34.28±
1.71; F2,22=−10.56, p=.003).
Associations between outcome expectancies and responses
to endotoxin administration
Spearman’s rank correlations of generalized and specific out-
come expectancies with the clinical, autonomic, and immune
response elicited by endotoxin administration are reported in
Table 1.
A higher degree of optimism was associated with higher
plasma epinephrine levels (Rho=0.76, p<.01) and IL-10
levels (Rho=0.60, p<.05). Neuroticism was not significantly
associated with the response to endotoxin administration. A
more positive expectation of the effects of the training was
associated with a lower flu-like clinical symptom report
(Rho=−0.71, p<.01).
Discussion
This proof-of-principle study in a relatively small sample of
healthy young men provides first indications that the generalized
outcome expectancy optimism is a potential determinant of the
autonomic and immune response to intravenous administration
of bacterial endotoxin after a short-term training program
consisting of meditation, breathing exercises, and cold exposure.
More specific outcome expectancies related to the training’s ef-
fects may be especially relevant for the clinical symptom report.
The results found for generalized outcome expectancies of
optimism are in line with previous studies demonstrating an
association between optimism and both stress and immune
system functioning e.g., [18–20]. However, this it is to our
knowledge the first study to suggest that optimism contributes
to an increased autonomic and repressed evoked immune re-
sponse in a standardized and reproducible experimental in-
flammation model. Also, the finding that specific outcome
expectancies are especially related to clinical symptom report
(e.g., pain experience) corresponds with previous research [6,
20]. That generalized and specific outcome expectancies re-
garding the effects of the training were not associated with
similar aspects of the response to endotoxin administration is
in line with a previous study that showed that specific expec-
tancies regarding the level of experienced pain in response to
cold pressor did not mediate or moderate the association be-
tween optimism and pain experience [20]. Thus, generalized
and specific expectancies appear to independently impact clin-
ical and immune responses that are also relevant for rheumatic
diseases. Future research into the mechanisms responsible for
the effects of generalized and specific expectancies on clinical,
autonomic, and immune responses is warranted. However, the
results of this study should be interpreted with caution and
need to be replicated in larger samples in order to show its
stability and generalizability. Also, examining these associa-
tions in samples showing disturbed autonomic and immune
responses as part of the disease process, such as in chronic
inflammatory rheumatic conditions, would show their poten-
tial clinical relevance. The findings suggest a possible role of
especially optimism as a predictor of the autonomic and im-
mune response to inflammatory stress after a brief training
program. If replicated, these findings may be used for
predicting training responses and potentiate their effects by
means of optimism-inducing interventions e.g., [20,23,24] in
patients with immune-mediated rheumatic conditions.
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